A new turbidimetric method for assaying serum C-reactive protein based on phosphocholine interaction

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 11, 2009, Pages 1417-1422

  Tugirimana, Pierrot L ^a   Holderbeke, Astrid L ^a   Kint, Jos A ^a   Delanghe, Joris R ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

C reactive protein; Immunoturbidimetry; L index; Phospholipids; Soy oil

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; INTRALIPID; PHOSPHORYLCHOLINE; SOYBEAN OIL; TRIACYLGLYCEROL;

ARTICLE; ASSAY; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; HUMAN; PLASMA; PRIORITY JOURNAL; SERUM; TRIACYLGLYCEROL BLOOD LEVEL; TURBIDIMETRY;

BINDING SITES; C-REACTIVE PROTEIN; CALCIUM; FLOW CYTOMETRY; HUMANS; IONS; NEPHELOMETRY AND TURBIDIMETRY; PHOSPHOLIPIDS; SENSITIVITY AND SPECIFICITY;

EID: 73349110101     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.312     Document Type: Article

References (33)

1. Volanakis JE. Human C-reactive protein: expression, structure, and function. Mol Immunol 2001;38:189-197
2. Morley JJ, Kushner I. Serum C-reactive protein levels in disease. Ann NY Acad Sci 1982;389:406-418
3. Young B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology 1991;23:118-124
4. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem 2004;279:48487-48490
5. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-1812
6. Lingard H, Zehetmayer S, Maier M. Bacterial superinfection in upper respiratory tract infections estimated by increases in CRP values: a diagnostic follow-up in primary care. Scand J Prim Health Care 2008;26:211-215
7. Maheshwari N. How useful is C-reactive protein in detecting occult bacterial infection in young children with fever without apparent focus. Arch Dis Child 2006; 91:533-535
8. Johnson HL, Chiou CC, Cho CT. Application of acute phase reactants in infectious diseases. J Microbiol Immunol Infect 1999;32:73-82.
9. Deegan O, Walshe K, Kavanagh K, Doyle S. Quantitative detection of C-reactive protein using phosphocholinelabelled enzyme or microspheres. Anal Biochem 2003; 312:175-181
10. Heegaard PM, Pedersen HG, Jensen AL, Boas U. A robust quantitative solid phase immunoassay for the acute phase protein C-reactive protein (CRP) based on cytidine 59-diphosphocholine coupled dendrimers. J Immunol Methods 2009;343:112-118
11. Kint JA. A nephelometric assay of CRP with Intralipid as reagent. Clin Chem 2001;47(Suppl): A26 [abstract].
12. Rowe IR, Soutar AK, Pepys MB. Agglutination of intravenous lipid emulsion ('Intralipid') and plasma lipoproteins by C-reactive protein. Clin Exp Immunol 1986;66: 241-247
13. Tuckwell KR. Intralipid. Pharmacia and UpJohn product information. MIMS Annual 1997;19:1110-1111
14. Nesheim M, Samis J, Walker J, Becker L, Brufatto N, Fischer T, et al. Lipoprotein-complexed C-reactive protein and the biphasic transmittance waveform in critically ill patients. Blood Rev 2002;16(Suppl 1):S15-22.
15. Rowe IF, Soutar AK, Trayner IM, Thompson GR, Pepys MB. Circulating human C-reactive protein binds very low-density lipoproteins. Clin Exp Immunol 1984;58:237-244
16. Michels R, Foschum F, Kienle A. Optical properties of fat emulsions. Opt Express 2008;16:5907-5925
17. Bordier C, Andraud C, Charron E, Lafait J, Anastasiadou M, De Martino A. Illustration of a bimodal system in Intralipid-20% by polarized light scattering: experiments and modeling. Appl Phys A 2009;94:347-355
18. Van Staveren HJ, Moes CJ, Van Marie J, Prahl SA, Van Gemert MJ. Light scattering in Intralipid-10% in the wavelength range of 400-1100 nm. Appl Opt 1991;30: 4507-4514
19. Konsensuswerte der Deutschen Gesellschaft für Laboratoriumsmedizin der Deutschen Gesellschaft für Klinische Chemie und des Verbandes der Diagnostica-Industrie e.V. (VDGH). Clin Lab 1995;41:743-748
20. Fink PC, Römer M, Haeckel R, Fateh-Moghadam A, Delanghe J, Gressner AM, et al. Measurement of proteins with the Behring Nephelometer. A multicentre evaluation. J Clin Chem Clin Biochem 1989;27:261-276
21. Whicher JT, Ritchie RF, Johnson AM, Baudner S, Bienvenu J, Blirup-Jensen S, et al. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994;40:934-938
22. Pearson JR, Wells R, Wells A. Serum index identifies lipemic samples causing interference with bilirubin assay on Hitachi 717. Clin Chem 1991;37:2014-2015
23. De Haene H, Taes Y, Christophe A, Delanghe J. Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism. Clin Chem Lab Med 2006;44:220-222
24. Westgard JO. Method validation-the detection limit experiment. http://www.westgard.com/lesson29.htm. Accessed April 2009.
25. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun 1989;6:67-75.
26. Terpstra AH, Woodward CJ, Sanchez-Muniz FJ. Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation: visualisation by prestaining and rapid separation of serum lipoproteins from small volumes of serum. Anal Biochem 1981;111:149-157
27. Dominici R, Luraschi P, Franzini C. Measurement of Creactive protein: two high sensitivity methods compared. J Clin Lab Anal 2004;18:280-284
28. Ricós C, Alvarez V, Cava F, García-Lario JV, Hernández A, Jiménez CV, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59:491-500.
29. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF, et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. J Am Med Assoc 2009;302:37-48.
30. Dati F, Johnson AM, Whicher JT. The existing interim consensus reference ranges and the future approach. Clin Chem Lab Med 2001;39:1134-1136
31. Werner MH, Daum PR, McQuillan GM. The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol 2000;27: 2351-2359
32. Nazmi A, Victora CG. Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies BMC Public Health 2007;7:212; doi:10.1186/1471-2458-7-212.
33. Sodini I, Morin P, Olabi A, Jiminez-Flores R. Compositional and functional properties of buttermilk: a comparison between sweet, sour and whey buttermilk. J Diary Sci 2006;99:525-536